Contact
Please use this form to send email to PR contact of this press release:
Koligo Therapeutics to Participate in Maxim Group and M-Vest COVID-19 Virtual Conference Series on May 27, 2020
TO:
Matthew Lehman
Koligo Therapeutics, Inc.
+1 502-265-4830